Related Experiment Videos
Hypothyroxinemia and phenytoin toxicity: a vicious circle
1Department of Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Canada.
Drug Metabolism and Drug Interactions
|January 1, 1996
Summary
Hypothyroidism may increase phenytoin levels, leading to toxicity. This occurs through a cycle where phenytoin affects thyroid hormone metabolism, reducing the drug
Area of Science:
- Pharmacology
- Endocrinology
- Clinical Toxicology
Background:
- Phenytoin, an anticonvulsant, has a narrow therapeutic index and concentration-dependent kinetics.
- Hypothyroidism can inhibit hepatic drug metabolism, but its effect on phenytoin clearance is debated.
- Thyroid hormones (T4 and T3) are crucial for regulating hepatic enzyme activity, including those involved in drug metabolism.
Observation:
- A 63-year-old female patient presented with hypothyroidism (decreased free T4) and phenytoin toxicity.
- Three similar case reports were identified in the literature.
- This suggests a potential interaction between phenytoin and thyroid status.
Findings:
- Phenytoin may induce hepatic enzymes responsible for T4 and T3 metabolism.
- Reduced free T4 levels can decrease hepatic NADPH cytochrome P-450 reductase activity.
- This leads to reduced phenytoin hydroxylation by P-450 IIC9, increasing serum phenytoin concentrations.
Implications:
- A vicious cycle may exist where phenytoin toxicity exacerbates hypothyroidism and vice versa.
- Clinicians should monitor phenytoin levels in hypothyroid patients.
- Further research is needed to elucidate this complex drug-drug-hormone interaction.